Frontier Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-27,575
Closed -$160K 454
2021
Q2
$160K Buy
27,575
+1
+0% +$6 0.01% 413
2021
Q1
$194K Buy
+27,574
New +$185K 0.01% 366
2020
Q3
Sell
-38,874
Closed -$262K 376
2020
Q2
$262K Sell
38,874
-81,300
-68% -$616K 0.02% 293
2020
Q1
$764K Hold
120,174
0.12% 141
2019
Q4
$1.25M Buy
+120,174
New +$874K 0.2% 109
2018
Q4
Sell
-21,344
Closed -$627K 412
2018
Q3
$627K Sell
21,344
-6,916
-24% -$268K 0.06% 196
2018
Q2
$1.28M Buy
28,260
+1,175
+4% +$57.1K 0.18% 123
2018
Q1
$1.43M Sell
27,085
-365
-1% -$21.3K 0.2% 117
2017
Q4
$1.87M Buy
27,450
+4,690
+21% +$328K 0.3% 80
2017
Q3
$1.88M Buy
22,760
+835
+4% +$66.2K 0.27% 96
2017
Q2
$2.05M Sell
21,925
-275
-1% -$16.8K 0.31% 85
2017
Q1
$1.41M Sell
22,200
-875
-4% -$53.2K 0.22% 117
2016
Q4
$1.02M Sell
23,075
-17,200
-43% -$605K 0.17% 152
2016
Q3
$1.45M Sell
40,275
-515
-1% -$11K 0.22% 109
2016
Q2
$560K Sell
40,790
-14,545
-26% -$213K 0.09% 193
2016
Q1
$1.06M Sell
55,335
-3,860
-7% -$81.7K 0.09% 128
2015
Q4
$2.07M Sell
59,195
-27,700
-32% -$1.79M 0.33% 83
2015
Q3
$7.99M Buy
86,895
+13,550
+18% +$1.17M 1.26% 14
2015
Q2
$6.45M Buy
+73,345
New +$6.28M 0.99% 19

Other funds holding CLVS